Auxilium Pharmaceuticals LLC (AUXL)

Healthcare Pharmaceuticals & Medical Research Pharmaceuticals

Track Share on 𝕏

Stock chart
Ticker: AUXL Exchange: NSQ


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale
Past 90 days
 
Value bought
 
Value sold
 
Net insiders buying
 
Trades (buy and sell)
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Total value Details
2014-12-08 2014-12-05 S Sale

Lurker Nancy

Non-Executive Director
7,430 -42.6%
34.00
252,620 USD 		7,430 -42.6% 34.00 252,620 USD
2014-12-08 2014-12-05 S Sale

Lurker Nancy

Non-Executive Director
25,000 -58.9%
34.00
850,000 USD 		25,000 -58.9% 34.00 850,000 USD
2014-12-08 2014-12-05 S Sale

MCKEE WILLIAM

Non-Executive Director
18,000 -64.3%
34.00
612,000 USD 		18,000 -64.3% 34.00 612,000 USD
2014-12-08 2014-12-05 S Sale

ADAMS ADRIAN

CEO and President

Executive Director
40,000 -15.5%
33.97
1,358,704 USD 		40,000 -15.5% 33.97 1,358,704 USD
2014-12-08 2014-12-05 S Sale

FRIEDMAN PAUL A

Non-Executive Director
9,689 -48.3%
33.85
327,953 USD 		9,689 -48.3% 33.85 327,953 USD
2014-12-08 2014-12-04 S Sale

FRIEDMAN PAUL A

Non-Executive Director
20,000 -49.9%
33.67
673,452 USD 		20,000 -49.9% 33.67 673,452 USD
2014-12-04 2014-12-03 S Sale

FETZER OLIVER

Non-Executive Director
50,000 -72.3%
34.00
1,700,000 USD 		50,000 -72.3% 34.00 1,700,000 USD
2014-12-04 2014-12-02 S Sale

CLASSON ROLF A

Non-Executive Director
19,135 -65.7%
33.75
645,726 USD 		19,135 -65.7% 33.75 645,726 USD
2014-12-04 2014-12-02 S Sale

CLASSON ROLF A

Non-Executive Director
260,000 -89.9%
33.81
8,790,808 USD 		260,000 -89.9% 33.81 8,790,808 USD
2014-12-04 2014-12-02 S Sale

FETZER OLIVER

Non-Executive Director
50,000 -72.3%
34.03
1,701,635 USD 		50,000 -72.3% 34.03 1,701,635 USD
2014-11-26 2014-11-25 S Sale

JOBES ELIZABETH VARKI

Chief Compliance Officer

Officer
23,750 -63.3%
34.03
808,310 USD 		23,750 -63.3% 34.03 808,310 USD
2014-11-26 2014-11-25 S Sale

JOBES ELIZABETH VARKI

Chief Compliance Officer

Officer
4,052 -9.7%
34.05
137,964 USD 		4,052 -9.7% 34.05 137,964 USD
2014-11-26 2014-11-25 S Sale

Tursi James Patrick

Chief Medical Officer

Officer
3,151 -9.0%
34.13
107,534 USD 		3,151 -9.0% 34.13 107,534 USD
2014-11-26 2014-11-25 S Sale

Tursi James Patrick

Chief Medical Officer

Officer
10,562 -23.2%
34.12
360,394 USD 		10,562 -23.2% 34.12 360,394 USD
2014-11-24 2014-11-21 S Sale

KOVEN ANDREW I

EVP, CAO, GC and Secretary

Officer
134,375 -77.6%
33.43
4,492,412 USD 		134,375 -77.6% 33.43 4,492,412 USD
2014-11-24 2014-11-21 S Sale

KOVEN ANDREW I

EVP, CAO, GC and Secretary

Officer
5,308 -3.0%
33.44
177,518 USD 		5,308 -3.0% 33.44 177,518 USD
2014-11-24 2014-11-21 S Sale

Armstrong Jennifer Lou

Senior Vice President, HR

Officer
69,412 -82.4%
33.50
2,325,031 USD 		69,412 -82.4% 33.50 2,325,031 USD
2014-11-24 2014-11-21 S Sale

Armstrong Jennifer Lou

Senior Vice President, HR

Officer
6,391 -7.0%
33.50
214,075 USD 		6,391 -7.0% 33.50 214,075 USD
2014-11-24 2014-11-21 S Sale

Tursi James Patrick

Chief Medical Officer

Officer
5,000 -12.5%
33.49
167,432 USD 		5,000 -12.5% 33.49 167,432 USD
2014-11-24 2014-11-21 S Sale

Tursi James Patrick

Chief Medical Officer

Officer
3,648 -8.3%
33.45
122,011 USD 		3,648 -8.3% 33.45 122,011 USD
2014-11-24 2014-11-20 S Sale

WILLS ALAN

EVP, Corporate Development

Officer
13,717 -30.9%
33.18
455,086 USD 		13,717 -30.9% 33.18 455,086 USD
2014-11-24 2014-11-20 S Sale

WILLS ALAN

EVP, Corporate Development

Officer
142,875 -76.3%
33.18
4,740,207 USD 		142,875 -76.3% 33.18 4,740,207 USD
2014-11-24 2014-11-20 S Sale

Glickman Mark A

EVP - Sales and Marketing

Officer
40,750 -59.3%
33.16
1,351,372 USD 		40,750 -59.3% 33.16 1,351,372 USD
2014-11-24 2014-11-20 S Sale

Glickman Mark A

EVP - Sales and Marketing

Officer
7,202 -9.5%
33.18
238,963 USD 		7,202 -9.5% 33.18 238,963 USD
2014-11-24 2014-11-20 S Sale

Tursi James Patrick

Chief Medical Officer

Officer
59,800 -57.8%
33.18
1,983,871 USD 		59,800 -57.8% 33.18 1,983,871 USD
2014-11-24 2014-11-20 S Sale

Tursi James Patrick

Chief Medical Officer

Officer
6,200 -5.7%
32.94
204,253 USD 		6,200 -5.7% 32.94 204,253 USD
2014-03-17 2014-03-14 S Sale

DEL TITO BENJAMIN J JR

EVP, Reg Affairs & Project Mgt

Officer
524 -8.3%
29.55
15,484 USD 		524 -8.3% 29.55 15,484 USD
2014-03-17 2014-03-14 S Sale

DEL TITO BENJAMIN J JR

EVP, Reg Affairs & Project Mgt

Officer
883 -12.3%
29.55
26,093 USD 		883 -12.3% 29.55 26,093 USD
2014-03-17 2014-03-14 S Sale

DEL TITO BENJAMIN J JR

EVP, Reg Affairs & Project Mgt

Officer
30,625 -57.4%
29.50
903,438 USD 		30,625 -57.4% 29.50 903,438 USD
2014-03-06 2014-03-05 S Sale

CLASSON ROLF A

Non-Executive Director
10,000 -30.4%
31.85
318,477 USD 		10,000 -30.4% 31.85 318,477 USD
2013-12-16 2013-12-13 PS Planned sale

DEL TITO BENJAMIN J JR

EVP, Reg Affairs & Project Mgt

Officer
302 -6.9%
20.50
6,191 USD 		302 -6.9% 20.50 6,191 USD
2013-12-16 2013-12-13 S Sale

DEL TITO BENJAMIN J JR

EVP, Reg Affairs & Project Mgt

Officer
4,300 -49.6%
20.50
88,150 USD 		4,300 -49.6% 20.50 88,150 USD
2013-12-12 2013-12-11 PS Planned sale

Fickenscher James E

Chief Financial Officer

Officer
71,067 -61.2%
20.37
1,447,450 USD 		71,067 -61.2% 20.37 1,447,450 USD
2013-05-22 2013-05-20 S Sale

MCKEE WILLIAM

Non-Executive Director
2,000 -20.0%
15.10
30,209 USD 		2,000 -20.0% 15.10 30,209 USD
2012-06-26 2012-06-25 PS Planned sale

DEL TITO BENJAMIN J JR

EVP, Reg Affairs & Project Mgt

Officer
12,682 -73.9%
25.01
317,155 USD 		12,682 -73.9% 25.01 317,155 USD
2012-06-08 2012-06-06 S Sale

DEL TITO BENJAMIN J JR

EVP, Reg Affairs & Project Mgt

Officer
5,700 -73.8%
22.55
128,536 USD 		5,700 -73.8% 22.55 128,536 USD
2012-06-08 2012-06-06 S Sale

DEL TITO BENJAMIN J JR

EVP, Reg Affairs & Project Mgt

Officer
300 -3.7%
22.55
6,766 USD 		300 -3.7% 22.55 6,766 USD
2012-03-01 2012-02-28 B Purchase

Brandt Peter C.

Non-Executive Director
9,700 +3233.3%
20.10
194,970 USD 		9,700 +3233.3% 20.10 194,970 USD
2012-03-01 2012-02-28 B Purchase

Brandt Peter C.

Non-Executive Director
300 +inf%
20.09
6,028 USD 		300 +inf% 20.09 6,028 USD
2011-11-07 2011-11-03 B Purchase

Fickenscher James E

Chief Financial Officer

Officer
1,610 +6.4%
15.54
25,024 USD 		1,610 +6.4% 15.54 25,024 USD
2011-10-11 2011-10-07 PS Planned sale

ANIDO ARMANDO

CEO & President

Executive Director
5,275 -27.9%
14.23
75,046 USD 		5,275 -27.9% 14.23 75,046 USD
2011-08-03 2011-08-02 S Sale

Baker Brothers Life Sciences Capital (GP), LLC

Large shareholder
40,781 -0.7%
17.25
703,391 USD 		40,781 -0.7% 17.25 703,391 USD
2011-08-03 2011-08-02 S Sale

14159 capital (GP), LLC

Large shareholder
1,001 -0.7%
17.25
17,265 USD 		1,001 -0.7% 17.25 17,265 USD
2011-08-03 2011-08-02 S Sale

Baker / Tisch Capital (GP), LLC

Large shareholder
507 -0.7%
17.25
8,745 USD 		507 -0.7% 17.25 8,745 USD
2011-08-03 2011-08-02 S Sale

Baker Biotech Capital (GP), LLC

Large shareholder
6,361 -0.7%
17.25
109,715 USD 		6,361 -0.7% 17.25 109,715 USD
2011-08-03 2011-08-01 S Sale

Baker Brothers Life Sciences Capital (GP), LLC

Large shareholder
394,404 -6.7%
18.04
7,114,614 USD 		394,404 -6.7% 18.04 7,114,614 USD
2011-08-03 2011-08-01 S Sale

14159 capital (GP), LLC

Large shareholder
9,678 -6.7%
18.04
174,580 USD 		9,678 -6.7% 18.04 174,580 USD
2011-08-03 2011-08-01 S Sale

Baker / Tisch Capital (GP), LLC

Large shareholder
4,902 -6.7%
18.04
88,427 USD 		4,902 -6.7% 18.04 88,427 USD
2011-08-03 2011-08-01 S Sale

Baker Biotech Capital (GP), LLC

Large shareholder
61,519 -6.7%
18.04
1,109,735 USD 		61,519 -6.7% 18.04 1,109,735 USD
2011-08-03 2011-08-01 S Sale

Baker Brothers Life Sciences Capital (GP), LLC

Large shareholder
260,868 -4.3%
18.03
4,703,320 USD 		260,868 -4.3% 18.03 4,703,320 USD
2011-08-03 2011-08-01 S Sale

14159 capital (GP), LLC

Large shareholder
6,400 -4.3%
18.03
115,389 USD 		6,400 -4.3% 18.03 115,389 USD
2011-08-03 2011-08-01 S Sale

Baker / Tisch Capital (GP), LLC

Large shareholder
3,243 -4.3%
18.03
58,470 USD 		3,243 -4.3% 18.03 58,470 USD
2011-08-03 2011-08-01 S Sale

Baker Biotech Capital (GP), LLC

Large shareholder
40,690 -4.3%
18.03
733,620 USD 		40,690 -4.3% 18.03 733,620 USD
2011-07-12 2011-07-08 PS Planned sale

ANIDO ARMANDO

CEO & President

Executive Director
5,275 -27.9%
20.30
107,101 USD 		5,275 -27.9% 20.30 107,101 USD
2011-03-31 2011-03-30 B Purchase

14159 capital (GP), LLC

Large shareholder
3,911 +2.7%
21.98
85,963 USD 		3,911 +2.7% 21.98 85,963 USD
2011-03-31 2011-03-30 B Purchase

Baker Bros. Capital (GP), LLC

Large shareholder
309 +4.6%
21.98
6,792 USD 		309 +4.6% 21.98 6,792 USD
2011-03-31 2011-03-29 B Purchase

Baker Brothers Life Sciences Capital (GP), LLC

Large shareholder
82,000 +1.4%
21.94
1,798,670 USD 		82,000 +1.4% 21.94 1,798,670 USD
2011-03-31 2011-03-29 B Purchase

Baker Brothers Life Sciences Capital (GP), LLC

Large shareholder
250,000 +4.3%
22.00
5,499,400 USD 		250,000 +4.3% 22.00 5,499,400 USD
2011-03-10 2011-03-09 B Purchase

Baker Brothers Life Sciences Capital (GP), LLC

Large shareholder
550,000 +10.5%
22.75
12,513,765 USD 		550,000 +10.5% 22.75 12,513,765 USD
2011-03-10 2011-03-09 B Purchase

Baker Brothers Life Sciences Capital (GP), LLC

Large shareholder
115,000 +2.3%
23.44
2,695,060 USD 		115,000 +2.3% 23.44 2,695,060 USD
2011-03-10 2011-03-09 B Purchase

Baker Brothers Life Sciences Capital (GP), LLC

Large shareholder
117,273 +2.3%
23.17
2,717,344 USD 		117,273 +2.3% 23.17 2,717,344 USD
2011-03-10 2011-03-08 B Purchase

Baker Brothers Life Sciences Capital (GP), LLC

Large shareholder
58,388 +1.2%
22.81
1,331,976 USD 		58,388 +1.2% 22.81 1,331,976 USD
2011-03-10 2011-03-08 B Purchase

Baker Brothers Life Sciences Capital (GP), LLC

Large shareholder
1,948 +0.0%
22.51
43,845 USD 		1,948 +0.0% 22.51 43,845 USD
2011-03-10 2011-03-08 B Purchase

Baker Brothers Life Sciences Capital (GP), LLC

Large shareholder
48,657 +1.0%
22.86
1,112,299 USD 		48,657 +1.0% 22.86 1,112,299 USD
2011-03-10 2011-03-08 B Purchase

Baker Brothers Life Sciences Capital (GP), LLC

Large shareholder
86,227 +1.8%
22.88
1,972,693 USD 		86,227 +1.8% 22.88 1,972,693 USD
2011-03-10 2011-03-08 B Purchase

14159 capital (GP), LLC

Large shareholder
1,612 +1.1%
22.81
36,774 USD 		1,612 +1.1% 22.81 36,774 USD
2011-03-10 2011-03-08 B Purchase

14159 capital (GP), LLC

Large shareholder
54 +0.0%
22.51
1,215 USD 		54 +0.0% 22.51 1,215 USD
2011-03-10 2011-03-08 B Purchase

14159 capital (GP), LLC

Large shareholder
1,343 +0.9%
22.86
30,701 USD 		1,343 +0.9% 22.86 30,701 USD
2011-03-10 2011-03-08 B Purchase

14159 capital (GP), LLC

Large shareholder
2,380 +1.7%
22.88
54,449 USD 		2,380 +1.7% 22.88 54,449 USD
2011-03-10 2011-03-08 B Purchase

Baker Brothers Life Sciences Capital (GP), LLC

Large shareholder
10,996 +0.2%
23.05
253,503 USD 		10,996 +0.2% 23.05 253,503 USD
2011-03-10 2011-03-08 B Purchase

14159 capital (GP), LLC

Large shareholder
304 +0.2%
23.05
7,008 USD 		304 +0.2% 23.05 7,008 USD
2011-03-09 2011-03-08 PS Planned sale

ANIDO ARMANDO

CEO & President

Executive Director
5,275 -24.7%
23.03
121,502 USD 		5,275 -24.7% 23.03 121,502 USD
2011-03-09 2011-03-08 PS Planned sale

ANIDO ARMANDO

CEO & President

Executive Director
5,280 -24.7%
23.01
121,492 USD 		5,280 -24.7% 23.01 121,492 USD
2011-01-12 2011-01-10 PS Planned sale

ANIDO ARMANDO

CEO & President

Executive Director
5,275 -24.7%
23.27
122,723 USD 		5,275 -24.7% 23.27 122,723 USD
2011-01-12 2011-01-10 PS Planned sale

ANIDO ARMANDO

CEO & President

Executive Director
5,280 -24.7%
23.17
122,327 USD 		5,280 -24.7% 23.17 122,327 USD